Health ❯Medicine ❯Pharmaceuticals

Drug Development

Obesity Treatments Clinical Trials Alzheimer's Disease FDA Approval Weight Loss Treatments Pain Medication Inflammatory Bowel Disease ERR Protein Activation Semaglutide Research and Development Muscle-Activating Compounds

Scientists Renew Push to Ban 'Mirror Life' Research After New Warning

The technology is likely years away, yet experts want legal guardrails now due to profound dual‑use risks.

Wegovy Becomes First GLP-1 Therapy Approved by FDA for MASH

Novartis Ianalumab Meets Efficacy and Safety Goals in Phase 3 Sjögren’s Trials

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

Artificial Enzymes Designed by Computers Rival Natural Catalysts

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Cassava Sciences Settles SEC Charges Over Misleading Alzheimer's Drug Trial Data for $40M

Pfizer's New Drug Shows Promise in Combatting Cancer-Related Weight Loss

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea

Pfizer's Lorbrena Sets New Benchmark in Treating Advanced Lung Cancer

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

EU Regulators Clear Ozempic and Related Drugs of Suicidal Thoughts Link

Scientists Develop Pill Mimicking Exercise Benefits

Vertex's New Non-Opioid Painkiller VX-548 Shows Promise, But Raises Concerns